Mycology
[Mikológia]
EPTIS Ringversuch Nr. 1271721 | Letze Änderung 2026-03-19 | URL: https://www.eptis.bam.de/pts1271721 https://www.eptis.bam.de/pts1271721
| Name des Anbieters | |||||||||||||||||||||||||||||||
| Name des Anbieters | QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. | ||||||||||||||||||||||||||||||
| Ansässig in | Hungary | ||||||||||||||||||||||||||||||
| Sprache(n) | English, Hungarian | ||||||||||||||||||||||||||||||
| Anmerkungen | Identification of strains involved in fungus infection and determination of antimycotic sensitivity according to the rules of the profession, in which case you would do so during routine diagnostics as well. QualiCont has had accredited status as the QualiCont as a Proficiency Test Provider complies with the criteria of MSZ EN ISO/IEC 17043:2010 standard since 26 March 2014. The QualiCont has been accredited according to the MSZ EN ISO/IEC 17043:2023 standard since 18 December 2025. Our Company is a Proficiency Testing Provider Organisation accredited by NAH (National Accreditation Authority) under the NAH-8-0002/2023 registration number. As the result of the accreditation process performed by NAH, our Company has accredited status until 9 March 2028. QualiCont Nonprofit Kft. has been operating its quality management system since 2001. Our Company successfully passed the renewal audit on 6th May, 2025. The certificate is valid until 28 May 2028. Our Company has been assessed and certified as meeting the requirements of ISO 9001:2015 standard for the following activities: Planning, organization and management of proficiency testing (external quality assessment) and the related supporting services for in vitro medical diagnostic laboratories and investigators on other human and veterinary medicine. | ||||||||||||||||||||||||||||||
| Klassifizierung | |||||||||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
Human test material |
||||||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | In vitro medical laboratories | ||||||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances | ||||||||||||||||||||||||||||||
| Weitere Ziele | validation of testing methods | ||||||||||||||||||||||||||||||
| Teilnehmerzahl | |||||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch NAH (National Accreditation Authority) auf der Grundlage von ISO/IEC 17043:2010 |
||||||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||||||||||||||
| Kosten | |||||||||||||||||||||||||||||||
| Teilnahmegebühr | on demand | ||||||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (four times a year) | ||||||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2001 | ||||||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||||||||||||||
|
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7 6720 Szeged Hungary Telefon: +36 30 462 5864 Fax: Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html |
Ms. Eszter Mezey
Telefon: +36 30 462 5864 Fax: E-Mail: mail@qualicont.com mail@qualicont.com |
||||||||||||||||||||||||||||||